3/18
02:00 pm
nvo
Novo Nordisk A/S (NVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock.
Low
Report
Novo Nordisk A/S (NVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock.
3/18
12:45 pm
nvo
Novo Nordisk initiated with an Underperform at Bernstein
Low
Report
Novo Nordisk initiated with an Underperform at Bernstein
3/18
12:45 pm
nvo
Novo Nordisk initiated with an Underperform at Bernstein
Low
Report
Novo Nordisk initiated with an Underperform at Bernstein
3/3
08:43 am
nvo
Novo Nordisk A/S (NVO) was upgraded by Morgan Stanley from "underweight" to "equal weight". They now have a $40.00 price target on the stock.
Low
Report
Novo Nordisk A/S (NVO) was upgraded by Morgan Stanley from "underweight" to "equal weight". They now have a $40.00 price target on the stock.
3/3
08:43 am
nvo
Novo Nordisk A/S (NVO) was upgraded by Morgan Stanley from "underweight" to "equal weight". They now have a $40.00 price target on the stock.
Low
Report
Novo Nordisk A/S (NVO) was upgraded by Morgan Stanley from "underweight" to "equal weight". They now have a $40.00 price target on the stock.
3/3
04:31 am
nvo
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley
Low
Report
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley
3/3
04:31 am
nvo
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley
Low
Report
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley
3/2
07:00 am
nvo
Rating for NVO
Low
Report
Rating for NVO
3/2
07:00 am
nvo
Rating for NVO
Low
Report
Rating for NVO
3/2
07:00 am
nvo
Rating for NVO
Low
Report
Rating for NVO
3/2
04:23 am
nvo
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
Low
Report
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
3/2
04:23 am
nvo
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
Low
Report
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
3/2
04:23 am
nvo
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
Low
Report
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
2/24
08:00 am
nvo
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating.
Low
Report
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating.
2/24
08:00 am
nvo
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.
Low
Report
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.
2/24
06:41 am
nvo
Rating for NVO
Low
Report
Rating for NVO
2/24
06:03 am
nvo
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Nordea Equity Research to a "hold" rating.
Low
Report
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Nordea Equity Research to a "hold" rating.
2/24
05:04 am
nvo
Novo Nordisk downgraded to Hold from Buy at Nordea
Low
Report
Novo Nordisk downgraded to Hold from Buy at Nordea
2/24
05:04 am
nvo
Novo Nordisk downgraded to Hold from Buy at Nordea
Low
Report
Novo Nordisk downgraded to Hold from Buy at Nordea
2/24
04:30 am
nvo
Novo Nordisk downgraded to Hold from Buy at Kepler Cheuvreux
Low
Report
Novo Nordisk downgraded to Hold from Buy at Kepler Cheuvreux
2/24
04:27 am
nvo
Novo Nordisk downgraded to Neutral from Overweight at JPMorgan
Low
Report
Novo Nordisk downgraded to Neutral from Overweight at JPMorgan
2/23
08:21 am
nvo
Novo Nordisk downgraded to Hold from Buy at Deutsche Bank
Low
Report
Novo Nordisk downgraded to Hold from Buy at Deutsche Bank
2/23
08:21 am
nvo
Novo Nordisk downgraded to Hold from Buy at Deutsche Bank
Low
Report
Novo Nordisk downgraded to Hold from Buy at Deutsche Bank
2/12
04:50 am
nvo
Novo Nordisk upgraded to Hold from Underperform at Jefferies
Low
Report
Novo Nordisk upgraded to Hold from Underperform at Jefferies
2/12
04:50 am
nvo
Novo Nordisk upgraded to Hold from Underperform at Jefferies
Low
Report
Novo Nordisk upgraded to Hold from Underperform at Jefferies